ZLAB241220C15000
- 0.00
- 0.000.00%
Zai Lab Newsroom
The Concept of Innovative Drugs mostly rose, with Shengnuo Pharmaceutical (02257) increasing by 11.56%. Institutions indicate that pharmaceutical innovation is the core driving force of pharmaceutical growth.
Jinwu Finance | Most Innovative Drug Concepts have risen, with Saint Nutra Pharma (02257) up 11.56%, Baiao Saitu (02315) up 9.68%, Geli Pharma (01672) up 7.98%, Lvzhu Bio (02480) up 4.73%, ZAI LAB (09688) up 4.41%, Connaught (02162) up 1.34%, SINO BIOPHARM (01177) up 0.95%, INNOVENT BIO (01801) up 0.69%. Galaxy Securities stated that 1) pharmaceutical innovation is the core driving force of pharmaceutical growth. Innovative drugs have transitioned from Me-too to
Before the Federal Reserve's decision, the rally of U.S. stocks faltered, the Nasdaq said goodbye to record highs, the Dow fell for nine consecutive days, Broadcom dropped over 4%, Chinese concept stocks rebounded against the trend, and Bitcoin reached a
The Dow Jones has seen its first nine consecutive declines since 1978; NVIDIA has seen four consecutive declines, while Tesla has risen over 3% against the trend, hitting new highs for three consecutive days. Chinese concept stocks rebounded nearly 2%, with PDD Holdings rising nearly 3% and Bilibili increasing over 4%. Salaries in the United Kingdom have grown faster than expected, with two-year UK bond yields rising 10 basis points in one day. The USD has rebounded; the Canadian dollar has hit a more than four-year low since the pandemic; Bitcoin surged over $0.108 million during trading, hitting a new historical high for two consecutive days. Crude Oil Product has fallen for two consecutive days, with US oil dropping more than 2% at one point; Gold has hit a new low for the week.
ZAI LAB (09688) issues 8 million shares.
ZAI LAB (09688) announced that on December 17, 2024, the company will issue 8 million new ordinary shares...
Further Weakness as Zai Lab (NASDAQ:ZLAB) Drops 8.9% This Week, Taking Three-year Losses to 61%
Zai Lab Announces Participation in Investor Conference in January 2025
China to Lift Fiscal Spending to Boost Economy
China Central Economic Work Conference: A Key Indicator for Future Market Trends
Tonight, Chinese concepts soared! The nasdaq Golden Dragon index surged by 10%, while fangdd network doubled directly.
Some analysis indicates that the Political Bureau meeting first mentioned stabilizing the stock and real estate markets, and the US stock market quickly rallied on china assets. The 3x Long FTSE china etf surged over 26%, the 2x Long china internet plus-related stocks rose over 22%, the 2x Long FTSE china 50 ETF increased over 17%, and the 2x Long 300etf gained nearly 15%.
China Will Adopt a "Moderately Accommodative" Monetary Policy in the Next Year, The First Shift to Easing Since 2011
Express News | China Signals Major Policy Shift: Hang Seng and Chinese Stocks Rally on Easing Measures
The U.S. bioterrorism law has undergone significant changes, the CRO concept has launched a major counterattack, and WuXi AppTec is excited!
Industry pessimistic expectations may improve.
How to break through the challenges in the development of innovative drugs? The industry suggests focusing on internationalization.
① The year 2024 will be the inaugural year of large-scale authorized trade, and going abroad has become an important direction for the development of local pharmaceutical companies; ② Chinese企业品牌, clinical trial capabilities, data presentation formats, and levels of international operation still need time and practical verification.
Asian Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
Zai Lab Ltd Issues Restricted Share Units to Employees
Hong Kong stock abnormal | zai lab (09688) rose more than 4%, tumor electric field treatment of pancreatic cancer ushered in a breakthrough, positive main results of phase 3 PANOVA-3 study.
zai lab (09688) rose more than 4%, as of the time of publication, it rose by 4.67%, to 23.55 Hong Kong dollars, with a turnover of 16.0669 million Hong Kong dollars.
NovoCure's Tumor-Treating Electric Fields Shows Promise In Pancreatic Cancer Patients
Sector Update: Health Care Stocks Mixed Pre-Bell Monday
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Monday Ahead of Week Promising Crucial Economic Data
Zai Lab, NovoCure Say Pancreatic Cancer Trial Meets Primary Endpoint
Express News | Zai Lab and Novocure Announce Positive Topline Results From Phase 3 Panova-3 Clinical Trial of Tumor Treating Fields (Ttfields) Therapy for Pancreatic Cancer